Metapneumovirus Infection

Top drugs studied for this disease

CLINICAL_TRIALS trial_result · 2026-04-23
Clinical Trial Update: Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older [Phase 1]
A Phase 1 study of a vaccine candidate against respiratory syncytial virus, metapneumovirus, and parainfluenza virus type 3 in adults aged 6…